Skip to main content
Erschienen in: Reactions Weekly 1/2017

01.12.2017 | Case report

Adefovir/entecavir

Creatine kinase increased: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

A real-world retrospective clinical study described a patient [age and sex not stated], who showed increased creatine kinase during the two-year combination therapy treatment with adefovir and entecavir for chronic hepatitis B [route, dosage, duration of treatment to reaction onset and outcome not stated]. …
Literatur
Zurück zum Zitat Wang M-L, et al. Efficacy and safety of three adefovir-based combination therapies in HBeAg-positive chronic hepatitis B patients with suboptimal response to adefovir monotherapy. Journal of Viral Hepatitis 24 (Suppl. 1): 21-28, Nov 2017. Available from: URL: http://doi.org/10.1111/jvh.12792 - China Wang M-L, et al. Efficacy and safety of three adefovir-based combination therapies in HBeAg-positive chronic hepatitis B patients with suboptimal response to adefovir monotherapy. Journal of Viral Hepatitis 24 (Suppl. 1): 21-28, Nov 2017. Available from: URL: http://​doi.​org/​10.​1111/​jvh.​12792 - China
Metadaten
Titel
Adefovir/entecavir
Creatine kinase increased: case report
Publikationsdatum
01.12.2017
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2017
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-017-38950-4

Weitere Artikel der Ausgabe 1/2017

Reactions Weekly 1/2017 Zur Ausgabe

Case report

Multiple drug

Case report

Alectinib